We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PHARMACOR CINACALCET, AKM CINACALCET (Pharmacor Pty Ltd)
Product name
PHARMACOR CINACALCET, AKM CINACALCET
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
221 working days (255)
Active ingredients
cinacalcet hydrochloride
Registration type
New generic medicine
Indication
PHARMACOR CINACALCET, AKM CINACALCET (film-coated tablets) may be used to treat the biochemical manifestations of secondary hyperparathyroidism in patients with end stage renal disease, receiving dialysis. PHARMACOR CINACALCET, AKM CINACALCET should be used as adjunctive therapy.
PHARMACOR CINACALCET, AKM CINACALCET is also indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma.
PHARMACOR CINACALCET, AKM CINACALCET may also be used to treat the biochemical manifestations of primary hyperparathyroidism in patients for whom parathyroidectomy is not a treatment option.